| Managed by: |
Weatherall Institute of Molecular Medicine (WIMM) |
| Description: |
The TAL analyses human samples from national and international Phase I to Phase III trials of novel targeted therapies that maximise patient impact, transform understanding of disease biology and dissect mechanisms of action of therapies and mechanisms of response. |
Contact information
For more information, contact:
